These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6251738)

  • 1. A screening test for influenza immunity: preimmunization antibody titers to influenza virus antigens in atopic patients.
    Girsh LS; Spector S; Patel C; Friedman H
    Ann Allergy; 1980 Sep; 45(3):163-6. PubMed ID: 6251738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective immunization against influenza in pediatric renal transplant recipients.
    Edvardsson VO; Flynn JT; Deforest A; Kaiser BA; Schulman SL; Bradley A; Palmer J; Polinsky MS; Baluarte HJ
    Clin Transplant; 1996 Dec; 10(6 Pt 1):556-60. PubMed ID: 8996778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of influenza vaccination in adult liver transplant recipients.
    Soesman NM; Rimmelzwaan GF; Nieuwkoop NJ; Beyer WE; Tilanus HW; Kemmeren MH; Metselaar HJ; de Man RA; Osterhaus AD
    J Med Virol; 2000 May; 61(1):85-93. PubMed ID: 10745238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C; Sayan M; Sifil A; Artuk C; Yilmaz N; Bahar H; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):71-6. PubMed ID: 12745749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against human and swine-like influenza A: serological response to two inactivated vaccines of different formulation.
    Cuneo-Crovari P; Giacometti G; Gasparini R; Fontana G
    Boll Ist Sieroter Milan; 1976; 55(5):371-8. PubMed ID: 1016590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of antibodies to A/New Jersey/76, A/Victoria/3/75 and B/Hong Kong/5/72 influenza viruses in the population of Milan examined in the late spring of 1976 and evaluation of the past experience of the same population with probable agent of the 1918-20 pandemics].
    Profeta ML; Ferrante P
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):272-8. PubMed ID: 1016579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.
    Brydak LB; Machała M; Centkowski P; Warzocha K; Biliński P
    Vaccine; 2006 Nov; 24(44-46):6620-3. PubMed ID: 16870313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
    de Jong JC; Beyer WE; Palache AM; Rimmelzwaan GF; Osterhaus AD
    J Med Virol; 2000 May; 61(1):94-9. PubMed ID: 10745239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
    Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
    Zeman AM; Holmes TH; Stamatis S; Tu W; He XS; Bouvier N; Kemble G; Greenberg HB; Lewis DB; Arvin AM; Dekker CL
    Pediatr Infect Dis J; 2007 Feb; 26(2):107-15. PubMed ID: 17259871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influenza in Umbria from September 1977 to May 1978].
    Iorio AM; Cerbini C
    Boll Ist Sieroter Milan; 1979 May; 58(2):182-5. PubMed ID: 554621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E; Thraenhart O; Werner J; Höher PG
    Med Klin; 1980 Oct; 75(21):755-8. PubMed ID: 7453623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
    Oren S; Mandelboim M; Braun-Moscovici Y; Paran D; Ablin J; Litinsky I; Comaneshter D; Levartovsky D; Mendelson E; Azar R; Wigler I; Balbir-Gurman A; Caspi D; Elkayam O
    Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific antibody response after influenza immunization in systemic lupus erythematosus.
    Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
    J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seroepidemiologic survey for A/PR/8/34 (H1N1) virus from Chinese residents].
    Guo Y; Qi J; Wang M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):223-5. PubMed ID: 12526320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
    Skowronski DM; Tweed SA; De Serres G
    J Infect Dis; 2008 Feb; 197(4):490-502. PubMed ID: 18275271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.